Comparison of Murraya koenigii- and Tribulus terrestris-Based Oral Formulation Versus Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Men Aged >50 Years: A Double-Blind, Double-Dummy, Randomized Controlled Trial

Clinical Therapeutics

Volumn 33, Issue 12, 2011, Pages 1943-1952

  Sengupta, Gairik ^a   Hazra, Avijit ^b   Kundu, Anup ^b   Ghosh, Anirban ^c  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c East India Pharmaceutical Works Limited   (India)

Author keywords

Benign prostatic hyperplasia; Murraya koenigii; Randomized controlled trial; Tamsulosin; Tribulus terrestris

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; MURRAYA KOENIGII EXTRACT; MURRAYA KOENIGII EXTRACT PLUS TRIBULUS TERRESTRIS EXTRACT; PROSTALYN; TAMSULOSIN; TRIBULUS TERRESTRIS EXTRACT; UNCLASSIFIED DRUG; VELTAM;

ADULT; AGED; ALLERGIC RHINITIS; ARTHRALGIA; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG FORMULATION; DRUG TOLERABILITY; DYSPEPSIA; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MALE; PROSTATE HYPERTROPHY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SKIN INFECTION; URINARY TRACT INFECTION; URINE FLOW RATE;

ADMINISTRATION, ORAL; AGED; ANALYSIS OF VARIANCE; CAPSULES; DOUBLE-BLIND METHOD; HUMANS; MALE; MEDICATION ADHERENCE; MEDICINE, AYURVEDIC; MIDDLE AGED; MURRAYA; ORGAN SIZE; PLANT EXTRACTS; PLANTS, MEDICINAL; PROSTATE; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME; TRIBULUS; URODYNAMICS;

EID: 83455196171     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.11.005     Document Type: Article

References (33)

1. Neal D.E., Kelly J.D. The prostate and seminal vesicles. Bailey and Love's Short Practice of Surgery 2004, 1370-1387. Arnold Publishers, London, United Kingdom. 24th ed. R.C. Russell, N.S. Williams, C.J. Bulstrode (Eds.).
2. Roehrborn C.G., McConnell J.D. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. Campbell's Urology 2002, 1297-1336. WB Saunders Co, Philadelphia, PA. 8th ed. P.C. Walsh, A.B. Retik, E.D. Vaughan, A.J. Wein (Eds.).
3. Roehrborn C.G. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU Int 2008, 101(Suppl 3):17-21.
4. Djavan B. Treatment of symptomatic benign prostatic hyperplasia: current and future clinical practice in Europe-what is really happening?. Eur Urol Suppl 2007, 6:446-453.
5. Bent S., Kane C., Shinohara K., et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006, 354:557-566.
6. Melo E.A., Bertero E.B., Rios L.A., et al. Evaluating the efficiency of a combination of Pygieum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo controlled trial. Int Braz J Urol 2002, 28:418-425.
7. Zhang W., Wang X., Liu Y., et al. Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia. J Med Food 2008, 11:207-214.
8. Noguchi M., Kakuma T., Tomiyasu K., et al. Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms: a double-blind, placebo-controlled randomized and dose-ranging study. Asian J Androl 2008, 10:651-658.
9. Murraya koenigii. The Treatise on Indian Medicinal Plants 1994, Vol 3:107-108. Publications & Information Directorate, Council of Scientific & Industrial Research, New Delhi, India. A. Chatterjee, S.C. Pakrashi (Eds.).
10. Murraya koenigii (Linn.) Spreng. (Kaidarya-nimba). Quality Standards of Indian Medicinal Plants 2003, Vol 1:142-149. coordinator, Indian Council of Medical Research, New Delhi, India. A.K. Gupta (Ed.).
11. Ramsewak R.S., Nair M.G., Strasburg G.M., et al. Biologically active carbazole alkaloids from Murraya koenigii. J Agricult Food Chem 1999, 47:444-447.
12. Khan B.A., Abraham A., Leelamma S. Murraya koenigii and Brassica juncea-alterations on lipid profile in 1,2-dimethylhydrazine induced colon carcinogenesis. Invest New Drugs 1996, 14:365-369.
13. Tribulus terrestris. The Treatise on Indian Medicinal Plants 1994, Vol 3:128-130. Publications & Information Directorate, Council of Scientific & Industrial Research, New Delhi, India. A. Chatterjee, S.C. Pakrashi (Eds.).
14. Antonio J. The effects of Tribulus terrestris on body composition and exercise performance in resistance-trained males. Int J Sport Nutr Exercise Metabol 2000, 10:208-215.
15. Westfall T.C., Westfall D.P. Adrenergic agonists and antagonists. Goodman & Gilman's The Pharmacological Basis of Therapeutics 2011, 277-333. McGraw Hill, New York, NY. 12th ed. L. Brunton, B. Chabner, B. Knollman (Eds.).
16. Ethical Guidelines for Biomedical Research on Human Participants 2006, Indian Council of Medical Research, New Delhi, India, Accessed November 28, 2011. http://icmr.nic.in/ethical_guidelines.pdf.
17. Bosch J.L., Hop W.C., Kirkels W.J., Schroder F.H. The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995, 75:622-630.
18. Roehrborn C.G., Siami P., Barkin J., et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol 2010, 57:123-131. CombAT Study Group.
19. Pinto F., Racioppi M., Sacco E., et al. Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasia. Arch Ital Urol Androl 2009, 81:1-8.
20. Fine S.R., Ginsberg P. Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications. J Am Osteopath Assoc 2008, 108:333-337.
21. Masumori N., Tsukamoto T., Iwasawa A., et al. Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study. Urol Int 2009, 83:49-54. Hokkaido Urological Disorders Conference Writing Group.
22. Jeong Y.B., Kwon K.S., Kim S.D., Kim H.J. Effect of discontinuation of 5alpha-reductase inhibitors on prostate volume and symptoms in men with BPH: a prospective study. Urology 2009, 73:802-806.
23. Gravas S., Oelke M. Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH. World J Urol 2010, 28:9-15.
24. Nayak A., Mandal S., Banerji A., Banerji J. Review on chemistry and pharmacology of Murraya koenigii Spreng (Rutaceae). J Chem Pharm Res 2010, 2:286-299.
25. Roy M.K., Thalang V.N., Trakoontivakorn G., Nakahara K. Mahanine, a carbazole alkaloid from Micromelum minutum, inhibits cell growth and induces apoptosis in U937 cells through mitochondrial dependent pathway. Br J Pharmacol 2005, 145:145-155.
26. Sinha S., Pal B.C., Jagadeesh S., et al. Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases. Prostate 2006, 66:1257-1265.
27. Jagadeesh S., Sinha S., Bhattacharya S., et al. Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells. Biochem Biophys Res Comm 2007, 362:212-217.
28. Gauthaman K., Ganesan A.P. The hormonal effects of Tribulus terrestris and its role in the management of male erectile dysfunction-an evaluation using primates, rabbit and rat. Phytomedicine 2008, 15:44-54.
29. Bedir E., Khan I.A., Walker L.A. Biologically active steroidal glycosides from Tribulus terrestris. Pharmazie 2002, 57:491-493.
30. Agrawal C.S., Chalise P.R., Bhandari B.B. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia. Nepal Med Coll J 2008, 10:104-107.
31. Yokoyama T., Hara R., Fukumoto K., et al. Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia. Int J Urol 2011, 18:225-230.
32. Miyakita H., Yokoyama E., Onodera Y., et al. Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia. Int J Urol 2010, 17:869-875.
33. Vidlar A., Vostalova J., Ulrichova J., et al. The effectiveness of dried cranberries (Vaccinium macrocarpon) in men with lower urinary tract symptoms. Br J Nutr 2010, 104:1181-1189.